Patient ID: f032f90d-a7f4-8f35-6e64-cac6ffd4d866
Name: Hershel911 Reilly981
Gender: male
Birth Date: 1928-03-02
Conditions: Chronic sinusitis (disorder); Risk activity involvement (finding); Serving in military service (finding); Educated to high school level (finding); Prediabetes (finding); Anemia (disorder); Body mass index 30+ - obesity (finding); Essential hypertension (disorder); Metabolic syndrome X (disorder); Chronic kidney disease stage 1 (disorder); Disorder of kidney due to diabetes mellitus (disorder); Has a criminal record (finding); Chronic kidney disease stage 2 (disorder); Microalbuminuria due to type 2 diabetes mellitus (disorder); Ischemic heart disease (disorder); Abnormal findings diagnostic imaging heart+coronary circulat (finding); Sleep disorder (disorder); Sleep apnea (disorder); Chronic kidney disease stage 3 (disorder); Proteinuria due to type 2 diabetes mellitus (disorder); Victim of intimate partner abuse (finding); Awaiting transplantation of kidney (situation); Chronic kidney disease stage 4 (disorder); Loss of teeth (disorder); Stress (finding); Medication review due (situation); Full-time employment (finding); Limited social contact (finding); Injury of neck (disorder); Whiplash injury to neck (disorder); Stress (finding); History of renal transplant (situation); Medication review due (situation); Medication review due (situation); Suspected prostate cancer (situation); Neoplasm of prostate (disorder); Carcinoma in situ of prostate (disorder); Gingivitis (disorder); Medication review due (situation); Chronic kidney disease stage 1 (disorder); Stress (finding); Medication review due (situation); Reports of violence in the environment (finding); Medication review due (situation); Stress (finding); Medication review due (situation); Limited social contact (finding); Medication review due (situation); Viral sinusitis (disorder); Acute viral pharyngitis (disorder); Medication review due (situation); Part-time employment (finding); Medication review due (situation); Medication review due (situation); Full-time employment (finding); Stress (finding); Social isolation (finding); Gingivitis (disorder); Medication review due (situation); Stress (finding); Reports of violence in the environment (finding); Gingival disease (disorder); Primary dental caries (disorder); Suspected lung cancer (situation); Medication review due (situation); Victim of intimate partner abuse (finding); Medication review due (situation); Non-small cell lung cancer (disorder); Non-small cell carcinoma of lung, TNM stage 1 (disorder); Medication review due (situation); Stress (finding); Gingivitis (disorder); Gingival disease (disorder); Fractured dental filling (finding); Victim of intimate partner abuse (finding); Reports of violence in the environment (finding); Stress (finding); Medication review due (situation); Medication review due (situation); Victim of intimate partner abuse (finding); Medication review due (situation); Medication review due (situation); Part-time employment (finding); Stress (finding); Full-time employment (finding); Died in hospice (finding)
Medications: 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet; Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; Naproxen sodium 220 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; 24 HR tacrolimus 1 MG Extended Release Oral Tablet; lisinopril 10 MG Oral Tablet; amLODIPine 2.5 MG Oral Tablet
